|
⚲
|
| Keyboard |
| Gangolli Julian S
✚
|
|
|---|---|
| CIK # | 0001532023 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001532023] | |
| 4 | [0001532023] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Gangolli Julian S | |
| Outlook Therapeutics Inc | |
| Krystal Biotech Inc | |
| Revance Therapeutics Inc | |
| GW Pharmaceuticals PLC | |
| Allergan Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Outlook Therapeutics Inc OTLK
Stock Option (Right to Buy) · derivative
|
2025-10-01 | Grant | 286,734 | $0.00 | |
|
Krystal Biotech Inc KRYS
Stock Option (Right to Buy) · derivative
|
2025-06-30 | Grant | 5,000 | $0.00 | |
|
Revance Therapeutics Inc RVNC
Common Stock
|
2025-02-06 | Disposed to issuer | 15,000 | ||
|
Revance Therapeutics Inc RVNC
Common Stock
|
2025-02-04 | Tender | 30,106 | $3.65 | 109,887 |
|
Outlook Therapeutics Inc OTLK
Stock Option (Right to Buy) · derivative
|
2024-10-01 | Grant | 56,636 | $0.00 | |
|
Outlook Therapeutics Inc OTLK
Stock Option (Right to Buy) · derivative
|
2024-10-01 | Grant | 71,169 | $0.00 | |
|
Krystal Biotech Inc KRYS
Stock Option (Right to Buy) · derivative
|
2024-06-30 | Grant | 5,000 | $0.00 | |
|
Krystal Biotech Inc KRYS
Common Stock
|
2024-05-20 | Sell | 10,930 | $163.71 | 1,789,350 |
|
Krystal Biotech Inc KRYS
Common Stock
|
2024-05-20 | Sell | 7,090 | $164.34 | 1,165,171 |
|
Krystal Biotech Inc KRYS
Common Stock
|
2024-05-20 | Sell | 1,980 | $165.76 | 328,205 |
|
Krystal Biotech Inc KRYS
Common Stock
|
2024-05-20 | Option exercise | 20,000 | $22.75 | 455,000 |
|
Krystal Biotech Inc KRYS
Stock Option (Right to Buy) · derivative
|
2024-05-20 | Option exercise | 20,000 | $0.00 | |
|
Revance Therapeutics Inc RVNC
Stock Option (Right to buy) · derivative
|
2024-05-01 | Grant | 23,458 | $0.00 | |
|
Revance Therapeutics Inc RVNC
Common Stock
|
2024-05-01 | Grant | 15,000 | $0.00 | |
|
Outlook Therapeutics Inc OTLK
Stock Option (Right to Buy) · derivative
|
2024-03-07 | Grant | 94,441 | $0.00 | |
|
Outlook Therapeutics Inc OTLK
Stock Option (Right to Buy) · derivative
|
2023-10-04 | Grant | 370,282 | $0.00 | |
|
Krystal Biotech Inc KRYS
Stock Option (Right to Buy) · derivative
|
2023-06-30 | Grant | 6,800 | $0.00 | |
|
Revance Therapeutics Inc RVNC
Common Stock
|
2023-05-03 | Grant | 3,534 | $0.00 | |
|
Revance Therapeutics Inc RVNC
Stock Option (Right to buy) · derivative
|
2023-05-03 | Grant | 5,915 | $0.00 | |
|
Outlook Therapeutics Inc OTLK
Stock Option (Right to Buy) · derivative
|
2023-03-29 | Grant | 41,065 | $0.00 | |
| showing 20 of 118 most recent transactions | |||||